miR-203 Inhibits the Proliferation and Self-Renewal of Esophageal Cancer Stem-Like Cells by Suppressing Stem Renewal Factor Bmi-1

被引:80
作者
Yu, Xiying [1 ,2 ,3 ]
Jiang, Xingran [1 ,2 ,3 ]
Li, Hongxia [1 ,2 ,3 ]
Guo, Liping [1 ,2 ,3 ]
Jiang, Wei [1 ,2 ,3 ]
Lu, Shih-Hsin [1 ,2 ,3 ]
机构
[1] Chinese Acad Med Sci, State Key Lab Mol Oncol, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci, Dept Etiol & Carcinogenesis, Canc Inst & Hosp, Beijing 100021, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
基金
中国国家自然科学基金;
关键词
CISPLATIN RESISTANCE; TUMOR-SUPPRESSOR; OVARIAN-CANCER; EXPRESSION; CARCINOMA; MICRORNA; IDENTIFICATION; PROTEIN; GENE; DIFFERENTIATION;
D O I
10.1089/scd.2013.0308
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Cancer stem-like cells exist in many malignancies and several stem cell-related genes and microRNAs, such as Bmi-1 and miR-203, have been identified as cancer stem-like cell regulators using gene microarray or sequencing analysis. Previously, we used side population (SP) sorting to enrich cancer stem-like cells from esophageal squamous cell carcinoma (ESCC) cell line EC9706. Our results demonstrated that EC9706 SP cells shared common features of cancer stem-like cells. In this study, we examined the expression of Bmi-1 and miR-203 in ESCC SP and non-SP (NSP) cells. Our results showed that, when compared with NSP cells, Bmi-1 was up-regulated and miR-203 was down-regulated in SP cells. During the differentiation from SP to NSP cells, the expression levels of Bmi-1 were gradually decreased. Overexpression of miR-203 resulted in a significant reduction of endogenous Bmi-1 protein level in EC9706 cells. SP and NSP analyses revealed that the SP cell fraction was markedly decreased in miR-203 overexpressed cells. miR-203 overexpressed cells also showed a significant reduction in colony formation, which was resistant to chemotherapeutic drug treatment and tumorigenicity in nude mice. Rescue experiments demonstrated that ectopic expression of Bmi-1 in miR-203 overexpressed cells increased the SP fraction and restored cell proliferation. Taken together, these results indicated that stem renewal factor Bmi-1 was a direct target of miR-203. The regulation of Bmi-1 by miR-203 may play an important role in controlling cell proliferation and self-renewal of esophageal cancer stem-like cells. It may also promote the development of new therapeutic strategies and efficient drugs that target ESCC stem-like cells.
引用
收藏
页码:576 / 585
页数:10
相关论文
共 43 条
[1]   Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma [J].
Angeles Castilla, Maria ;
Moreno-Bueno, Gema ;
Romero-Perez, Laura ;
Van De Vijver, Koen ;
Biscuola, Michele ;
Angeles Lopez-Garcia, Maria ;
Prat, Jaime ;
Matias-Guiu, Xavier ;
Cano, Amparo ;
Oliva, Esther ;
Palacios, Jose .
JOURNAL OF PATHOLOGY, 2011, 223 (01) :72-80
[2]   Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner [J].
Cui, Hongjuan ;
Ma, Jun ;
Ding, Jane ;
Li, Tai ;
Alam, Goleeta ;
Ding, Han-Fei .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (45) :34696-34704
[3]   Bmi-1 cooperates with H-ras to transform human mammary epithelial cells via Dysregulation of multiple growth-regulatory pathways [J].
Datta, Sonal ;
Hoenerhoff, Mark J. ;
Bommi, Prashant ;
Sainger, Rachana ;
Guo, Wei-Pan ;
Dimri, Manjari ;
Band, Hamid ;
Band, Vimla ;
Green, Jeffrey E. ;
Dimri, Goberdhan P. .
CANCER RESEARCH, 2007, 67 (21) :10286-10295
[4]   RETRACTED: shRNA knockdown of Bmi-1 reveals a critical role for p21-rb pathway in NSC self-renewal during development (Retracted article. See vol. 30, pg. 904, 2023) [J].
Fasano, Christopher A. ;
Dimos, John T. ;
Ivanova, Natalia B. ;
Lowry, Natalia ;
Lemischka, Ihor R. ;
Temple, Sally .
CELL STEM CELL, 2007, 1 (01) :87-99
[5]   MicroRNA expression profiles of esophageal cancer [J].
Feber, Andrew ;
Xi, Liqiang ;
Luketich, James D. ;
Pennathur, Arjun ;
Landreneau, Rodney J. ;
Wu, Maoxin ;
Swanson, Scott J. ;
Godfrey, Tony E. ;
Litle, Virginia R. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 135 (02) :255-260
[6]   Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function [J].
Fraser, Michael ;
Bai, Tao ;
Tsang, Benjamin K. .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (03) :534-546
[7]  
Gu J, 2013, CURR PHARM DESIGN, V19, P1292
[8]   Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells [J].
Guo, Wei-Jian ;
Zeng, Mu-Sheng ;
Yadav, Ajay ;
Song, Li-Bing ;
Guo, Bao-Hong ;
Band, Vimla ;
Dimri, Goberdhan P. .
CANCER RESEARCH, 2007, 67 (11) :5083-5089
[9]  
Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455
[10]  
Honig A, 2010, ANTICANCER RES, V30, P1559